Quantifying the release of biomarkers of myocardial necrosis from cardiac myocytes and intact myocardium

Clinical Chemistry

Volumn 63, Issue 5, 2017, Pages 990-996

  Marjot, Jack ^a   Kaier, Thomas E ^a   Martin, Eva D ^a   Reji, Shiney S ^b   Copeland, O'Neal ^b   Iqbal, Mohammed ^a   Goodson, Bob ^c   Hamren, Sarah ^c   Harding, Sian E ^b   Marber, Michael S ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c EMD Millipore Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; BIOLOGICAL MARKER; CARDIAC MYOSIN; CARDIAC MYOSIN BINDING PROTEIN C; CARDIAC TROPONIN T; CARDIAC TROPONIN T I; TROPONIN T; UNCLASSIFIED DRUG; TROPONIN I;

ADULT; ANIMAL CELL; ARTICLE; BLOOD; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CONTROLLED STUDY; HEART MUSCLE NECROSIS; HUMAN; HUMAN TISSUE; LIMIT OF QUANTITATION; MALE; NONHUMAN; PROTEIN DETERMINATION; RAT; SERUM; VENOUS CIRCULATION; ANIMAL; CHEMISTRY; CYTOLOGY; EATING; METABOLISM; MYOCARDIAL INFARCTION; SHEEP;

ANIMALS; BIOMARKERS; EATING; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; RATS; SHEEP; TROPONIN I;

EID: 85018305379     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2016.264648     Document Type: Article

References (27)

1. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012;60:1581-98.
2. Roffi M, Patrono C, Collet J-P, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016;37:267-315.
3. Reichlin T, Schindler C, Drexler B, Twerenbold R, Reiter M, Zellweger C, et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med 2012;172:1211- 8.
4. Rubini Giménez M, Twerenbold R, Jaeger C, Schindler C, Puelacher C, Wildi K, et al. One-hour rule-in and ruleout of acute myocardial infarction using high-sensitivity cardiac troponin I. Am J Med 2015;128: 861-4.
5. Twerenbold R, Wildi K, Jaeger C, Gimenez MR, Reiter M, Reichlin T, et al. Optimal cutoff levels of more sensitive cardiac troponin assays for the early diagnosis of myocardial infarction in patients with renal dysfunction. Circulation 2015;131:2041-50.
6. Chenevier-Gobeaux C, Meune C, Lefevre G, Doumenc B, Sorbets E, Peschanski N, et al. A single value of highsensitive troponin T below the limit of detection is not enough for ruling out non ST elevation myocardial infarction in the emergency department. Clin Biochem 2016;49:1113-7.
7. Kavsak PA, Saenger AK, Hickman PE. Reality check for cardiac troponin testing - sometimes the result is wrong. Clin Biochem 2016;49:1107- 8.
8. Hickman PE, Lindahl B, Cullen L, Koerbin G, Tate J, Potter JM. Decision limits and the reporting of cardiac troponin: meeting the needs of both the cardiologistand the ED physician. Crit Rev Clin Lab Sci 2015;52:28-44.
9. Hickman PE, Koerbin G, Saenger AK, Kavsak PA. Statistical issues with the determination of the troponin 99th percentile - not just a problem for troponin? Clin Biochem 2016;49:1105- 6.
10. De Nicola GF, Martin ED, Chaikuad A, Bassi R, Clark J, Martino L, et al. Mechanism and consequence of the autoactivation of p38- mitogen-Activated protein kinase promoted by TAB1. Nat Struct Mol Biol 2013;20: 1182-90.
11. Apple FS, Sandoval Y, Jaffe AS, Ordonez-Llanos J, for the IFCC Task Force on Clinical Applications of Cardiac Bio-Markers. Cardiac troponin assays: guide to understanding analytical characteristics and their impact on clinical care. Clin Chem 2017;63:73- 81.
12. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:254 - 61.
13. Ryan JB, Southby SJ, Stuart LA, Mackay R, Florkowski CM, GeorgePM.ComparisonofcardiacTnIoutliersusingacontemporaryandahigh- sensitivityassayonthe Abbott Architect platform. Ann Clin Biochem 2014;51:507-11.
14. Marjot J, Liebetrau C, Goodson RJ, Kaier T, Weber E, Heseltine P, et al. The development and application of a high-sensitivity immunoassay for cardiac myosinbinding protein C. Transl Res 2016;170:17-25;.
15. Baker JO, Tyther R, Liebetrau C, Clark J, Howarth R, Patterson T, et al. Cardiac myosin-binding protein C: A potential early biomarker of myocardial injury. Basic Res Cardiol 2015;110:23.
16. Starnberg K, Jeppsson A, Lindahl B, Hammarsten O. Revision of the troponin T release mechanism from damaged human myocardium. Clin Chem 2014;60: 1098 -104.
17. Katus HA, Remppis A, Scheffold T, Diederich KW, Kuebler W. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol 1991;67:1360-7.
18. Wu AH, Feng YJ, Moore R, Apple FS, McPherson PH, Buechler KF, Bodor GF. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. Clin Chem 1998;44:1198-208. Authors are on behalf of American Association for Clinical Chemistry Subcommittee on cTnI Standardization.
19. Govindan S, McElligott A, Muthusamy S, Nair N, Barefield D, Martin JL, et al. Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction. J Mol Cell Cardiol 2012;52: 154-64.
20. Cardinaels EPM, Mingels AMA, van Rooij T, Collinson PO, Prinzen FW, Van Dieijen-Visser MP. Time-dependent degradationpatternofcardiactroponinTfollowingmyocardial infarction. Clin Chem 2013;59:1083-90.
21. Sadayappan S, Osinska H, Klevitsky R, Lorenz JN, Sargent M, Molkentin JD, et al. Cardiac myosin binding protein C phosphorylation is cardioprotective. Proc Natl Acad Sci USA 2006;103:16918 -23.
22. Lipps C, Nguyen JH, Pyttel L, Lynch TL, Liebetrau C, Aleshcheva G, et al. N-Terminal fragment of cardiac myosin binding protein-C triggers pro-inflammatory responses in vitro. J Mol Cell Cardiol 2016;99:47-56.
23. Razzaque MA, Gupta M, Osinska H, Gulick J, Blaxall BC, Robbins J. An endogenously produced fragment of cardiac myosin-binding protein C is pathogenic and can lead to heart failure. Circ Res 2013;113: 553-61.
24. Gaze DC, Collinson PO. Multiple molecular forms of circulating cardiac troponin: Analytical and clinical significance. Ann Clin Biochem 2008;45:349 -55.
25. Turer AT, Addo TA, Martin JL, Sabatine MS, Lewis GD, Gerszten RE, et al. Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: insights from a coronary sinus sampling study. J Am Coll Cardiol 2011;57: 2398 - 405.
26. Selvanayagam JB. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation 2005; 111:1027-32.
27. Miner-Williams WM, Stevens BR, Moughan PJ. Are intact peptides absorbed from the healthy gut in the adult human? Nutr Res Rev 2014;27:308-29.